ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Ortho Biotec gives $1 Million To Fund Fatigue Initiative; Lippman, Pike Honored

November 18, 1994

Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network.

March 26, 2004

Cancer Prevention: Review Group’s Report Urges Integration Of Prevention with all NCI Research

June 27, 1997

NCI Cooperative Group, Cancer Center Trials Listed

September 28, 2007

GAO Decision Clears NCI to Deploy Medidata Rave Data Capture System

June 17, 2011

DCCP Board Approves Concept Of NMR Interintuitional Clinical Research

January 27, 1984